S&P 500 7,443.28 -0.19% NASDAQ 25,508.07 -0.05% DOW 51,839.26 -0.59% R2K 2,942.43 -0.67% VIX 18.65 -0.64% US 10Y 4.60 +1.26% DXY 100.97 +0.22% BITCOIN 65,299.99 +0.94%
Next Bullish Trade
Sign in
BRKR

Bruker Corporation BRKR

$56.17 -2.06 (-3.54%)
Pullback · -0.79σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BRKR

Momentum reads · latest daily bar
Last
$56.17
-2.06 (-3.54%)
Mkt cap
$8.6B
Healthcare
RSI(14)
46.3
neutral
Stochastic %K
27.5
neutral
MFI(14)
38.1
neutral
ADX(14)
26.1
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $0.8B $0.0B $0.0B $0.0B 1.7% 4.4%
2025-12-31 $1.0B $0.0B $0.1B $0.2B 2.7% 11.4%
2025-09-30 $0.9B $-0.1B $0.0B $-0.1B -6.9% 4.1%
2025-06-30 $0.8B $0.0B $0.0B $-0.1B 1.0% 3.3%
2025-03-31 $0.8B $0.0B $0.1B $0.0B 2.2% 8.6%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BRKR vs peers

Line BRKR up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BRKR no peers yet — add up to 4 below

Add tickers to compare with BRKR

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-06 0.31 0.23 +34.8% +3.4%
2026-02-12 0.59 0.65 -9.8% -2.7%
2025-11-03 0.45 0.32 +38.8% +4.3%
2025-08-04 0.32 0.42 -23.4% -7.6%
2025-05-07 0.47 0.44 +5.9% -0.6%
2025-02-13 0.76 0.74 +3.2% -2.2%
2024-11-05 0.60 0.60 -0.4% -3.9%
2024-08-06 0.52 0.51 +1.9% -3.0%
2024-05-02 0.53 0.46 +14.1% -0.1%
2024-02-13 0.70 0.66 +5.8% +4.2%
2023-11-02 0.74 0.63 +17.3% +4.3%
2023-08-03 0.50 0.49 +2.7% -1.9%
2023-05-04 0.64 0.55 +16.8% -3.7%
2023-02-09 0.74 0.72 +2.5% +3.9%
2022-11-03 0.66 0.56 +18.6% +4.2%
2022-08-03 0.45 0.45 -0.0% -7.1%
2022-05-04 0.49 0.42 +17.2% -4.7%
2022-02-11 0.59 0.58 +0.9% -3.4%
2021-11-01 0.63 0.44 +42.8% +0.5%
2021-08-02 0.44 0.38 +15.4% -2.1%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BRKR $9B 23.1 2.5 21.5 3.5 47.6% 2.7% -81.8% 2.49%
LLY 40.7 25.5 30.1 82.8% 55.5% 169.9%
UNH $383B 31.7 18.9 0.9 17.7 3.9 19.5% 0.4% 61.5% 5.95%
JNJ $599B 28.8 19.4 6.1 18.4 7.4 68.1% 6.6% -1.0%
MRK 35.1 12.9 12.1 6.7 76.7% 4.9%
ABBV $448B 124.2 15.6 7.1 17.2 -67.3 72.0% 12.4% -46.2% 4.65%
PFE 18.9 8.7 7.6 74.8% 5.4% -10.1%
TMO 28.9 19.3 21.1 40.9% 6.2% 11.3%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 51.14%

HolderShares% out
Orbis Allan Gray Ltd 17,940,076 11.79%
FMR, LLC 16,101,803 10.58%
Blackrock Inc. 11,180,806 7.34%
Pallas Capital Advisors Llc 9,481,821 6.23%
Vanguard Portfolio Management LLC 4,855,915 3.19%
Vanguard Capital Management LLC 4,817,076 3.16%
State Street Corporation 3,908,693 2.57%
Edmond De Rothschild Holding S.A. 3,356,850 2.21%
Sculptor Capital LP 3,270,000 2.15%
Franklin Resources, Inc. 2,919,177 1.92%

Insider activity · 90d

1 buys / 2 sells · ratio 0.5 · Finnhub

  • Munch Mark M 6,000
  • Munch Mark SELL 128,443 @ $54.76
  • Munch Mark M 130,443 @ $22.19
  • Bernard Thierry BUY 2,886
  • Munch Mark M 8,000
  • Munch Mark SELL 128,443 @ $43.90
  • Munch Mark M 130,443 @ $22.19

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$40.0
Mean
$59.75
High
$70.0
Analysts
12
Recommendation distribution · period 2026-07-01
6
8
6
1
Revision trend (2026-04-01 → 2026-07-01): net 14 → 13 -1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-16 Insider transaction (Form 4) view ·
4 2026-06-16 Insider transaction (Form 4) view ·
8-K 2026-05-21 8-K view ·
4 2026-05-19 Insider transaction (Form 4) view ·
4 2026-05-18 Insider transaction (Form 4) view ·
8-K 2026-05-15 8-K view ·
10-Q 2026-05-07 10-Q view ·
8-K 2026-05-06 8-K view ·
8-K 2026-04-28 8-K view ·
4 2026-04-16 Insider transaction (Form 4) view ·
DEF 14A 2026-04-10 DEF 14A view ·
8-K 2026-04-10 8-K view ·
8-K 2026-04-01 8-K view ·
4 2026-03-16 Insider transaction (Form 4) view ·
10-K 2026-02-27 10-K view ·
8-K 2026-02-20 8-K view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
4 2026-02-18 Insider transaction (Form 4) view ·
8-K 2026-02-12 8-K view ·
4 2026-01-16 Insider transaction (Form 4) view ·
4 2026-01-13 Insider transaction (Form 4) view ·
8-K 2026-01-12 8-K view ·
4 2026-01-06 Insider transaction (Form 4) view ·
8-K 2025-12-09 8-K view ·
4 2025-12-02 Insider transaction (Form 4) view ·
4 2025-11-10 Insider transaction (Form 4) view ·
10-Q 2025-11-05 10-Q view ·
8-K 2025-11-03 8-K view ·
4 2025-09-12 Insider transaction (Form 4) view ·
8-K 2025-09-08 8-K view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-19 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-12 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
4 2025-08-07 Insider transaction (Form 4) view ·
10-Q 2025-08-06 10-Q view ·
8-K 2025-08-04 8-K view ·
8-K 2025-07-21 8-K view ·
4 2025-06-09 Insider transaction (Form 4) view ·
8-K 2025-05-29 8-K view ·
4 2025-05-19 Insider transaction (Form 4) view ·
4 2025-05-14 Insider transaction (Form 4) view ·
8-K 2025-05-14 8-K view ·
10-Q 2025-05-07 10-Q view ·

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic for…

Options picks · BRKR

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BRKR

STOCK Act disclosures

Loading…

SEC filings & insiders · BRKR

EDGAR · live

Loading…

Holders · BRKR

Institutions & insider activity

Loading…